IRD · Opus Genetics, Inc. · Share Buybacks

$4.27 +0.34 (+8.65%) At close · Nov 4

Russell 2000 member Rebalance outlook locked

Market Cap

$326.96M

83.20M

Volume · Nov 4 1.16M Avg daily vol (3M) 2.48M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$50,000,000

as of 2023-08-10 · not restated in filings since 2024-05-10

Equity Offering (ATM) Programs

Program Established	Last Amended	Capacity	Sold	Remaining	Runs Through	Source
2025-01-13	—	$40,000,000	—	—	—	10-Q , filed 2025-08-13

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2012-03-31 YTD	$0	—	—	10-Q, filed 2012-05-09
2011-12-31	$0	—	—	10-K, filed 2012-03-16
2010-12-31	$0	—	—	10-K, filed 2012-03-16
2009-12-31	$0	—	—	10-K, filed 2012-03-16

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2012-03-31	$0	—	—	10-Q, filed 2012-05-09
2011-12-31	$0 Δ	—	—	10-K, filed 2012-03-16
2011-09-30	$0 Δ	—	—	10-Q, filed 2011-11-09
2011-06-30	$0 Δ	—	—	10-Q, filed 2011-08-09
2011-03-31	$0	—	—	10-Q, filed 2012-05-09
2010-12-31	$0 Δ	—	—	10-K, filed 2012-03-16
2010-09-30	$0 Δ	—	—	10-Q, filed 2011-11-09

Key facts CIK 1228627 CUSIP 67577R102 13F (30d) 23 filings 23 filers Visit website Investor relations